Bnip3L (Intermediate Domain) Blocking Peptide

Bnip3L (Intermediate Domain) Blocking Peptide

Product No.: B371

[product_table name="All Top" skus="B371"]

- -
- -
Target
Bnip3L
Product Type
Blocking Peptide
Alternate Names
Bnip, 3α, Nix

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Product Concentration
0.2 mg/ml
Amino Acid Location
Amino acids 77 to 92 of human origin, which are identical to those of mouse Bnip3L.
Formulation
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Handling
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Amino Acid Sequence
16 amino acids of human Bnip3L.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
Background
Bnip3L peptide is applicable as a control peptide for blocking antibody binding in Western blotting.

Antigen Details

References & Citations

1. Zamzami N, Kroemer G. Condensed matter in cell death. Nature 1999;401:127-8 3. Susin SA, Lorenzo HK, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999;397:441-6 2. Daugas E, Susin SA, Zamzami N, et al. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J 2000;14:729-39 (WD0500)
- -
- -
Products are for research use only. Not for use in diagnostic or therapeutic procedures.